Multi-omics analysis has emerged as a powerful approach in translational medicine, integrating diverse molecular data to ...

Biomarkers have become essential in the diagnosis and treatment of cancer, so it’s no surprise there is a race underway to uncover more of them. Cancer biomarkers—which include inherited or acquired ...

Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...

Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...

Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database ...

Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...

Omics framework of colorectal cancer liver metastasis. Genomic, epigenetic, transcriptomic, proteomic, metabolomic, and microbiomic analyses were performed on tissue from primary colorectal cancer ...

Phase 1a/1b study in 97 patients demonstrates mitochondrial metabolic reprogramming induced by BPM31510-IV and supports advancement in multiple ...

Relation's draw is its 'lab-in-a-loop' process of AI-driven target and drug discovery, in which algorithms are used to find ...

Through this partnership, Inotiv will integrate VUGENE’s cloud-based bioinformatics and computational platform into its Discovery & Translational Sciences Division, enabling a more efficient and ...